| Value | ₹103.1 Cr |
|---|
NSE filing, NSE: SYSTMTXC. Summary written from the filing by ALFA Finder's alert engine.
Systematix Corporate Services Ltd: key numbers
- Share price
- ₹74.00
- Market cap
- ₹1,010 Cr
- Revenue (annual)
- ₹146.2 Cr
- Net profit (annual)
- ₹13.85 Cr
- P/E (TTM)
- -672.7×Sector 19.8×
- Promoter holding
- 70.58%+0.00% QoQ
- FII holding
- 4.20%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Systematix Corporate Services Ltd
All →Systematix Corporate Services Other Announcement
Systematix Corporate Services Ltd has filed its quarterly shareholding pattern for the period ended 30th September 2026 as per Regulation 31 of SEBI LODR.
Systematix Corporate Services Merger & Restructuring Worth ₹10 Cr
Systematix Corporate Services will invest ₹10 Crore in its wholly-owned subsidiary, Systematix Wealth & Asset Services, by subscribing to a rights issue of equity shares.
- Value
- ₹10.00 Cr
Systematix Corporate Services Acquisition Worth ₹10 Cr
Systematix Corporate Services is investing ₹10 Crore via rights issue into its wholly-owned subsidiary, Systematix Wealth & Asset Services, for its working capital requirements.
- Value
- ₹10.00 Cr
Systematix Corporate Services Capital Structure Change
Systematix Corporate Services invested Rs. 10 Crore via a rights issue in its wholly-owned subsidiary, Systematix Wealth & Asset Services, to support working capital.
- Value
- ₹10.00 Cr
Systematix Corporate Services Management Change
Systematix Corporate Services declared a final dividend of Rs. 0.10 per share and re-appointed Mr. Nikhil Khandelwal as Managing Director for three years.
Systematix Corporate Services Annual General Meeting
Systematix Corporate Services held its 41st AGM on 22 Sep 2026, approving FY26 financials, a 10 paise dividend, and MD re-appointment. Routine governance resolutions were passed without member queries.
Other fund raise announcements
All →Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.
Gujarat Inject (Kerala) Fund Raise of ₹3 Cr
Gujarat Inject Kerala's board approved a Rs.3 Crore preferential warrant issue to public investors. Authorised capital will rise to Rs.17.63 Crore, subject to shareholder approval.
- Value
- ₹3.00 Cr